PRELUDE CAPITAL MANAGEMENT, LLC - AMPIO PHARMACEUTICALS INC ownership

AMPIO PHARMACEUTICALS INC's ticker is AMPE and the CUSIP is 03209T109. A total of 81 filers reported holding AMPIO PHARMACEUTICALS INC in Q2 2020. The put-call ratio across all filers is 0.22 and the average weighting 0.0%.

Quarter-by-quarter ownership
PRELUDE CAPITAL MANAGEMENT, LLC ownership history of AMPIO PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2021$50,000
+2400.0%
29,598
+1245.4%
0.00%
Q3 2020$2,000
+100.0%
2,2000.0%0.00%
Q2 2020$1,000
-90.0%
2,200
+82.9%
0.00%
-100.0%
Q2 2014$10,0001,2030.00%
Other shareholders
AMPIO PHARMACEUTICALS INC shareholders Q2 2020
NameSharesValueWeighting ↓
Shilanski & Associates, Inc. 937,237$57,0000.02%
PRIVATE CAPITAL MANAGEMENT LLC 937,237$57,0000.02%
CVA Family Office, LLC 1,137,920$69,0000.02%
Cypress Capital Management LLC (WY) 140,925$9,0000.01%
Helen Stephens Group, LLC 117,222$7,0000.01%
COURIER CAPITAL LLC 540,056$33,0000.00%
NORTHCAPE WEALTH MANAGEMENT, LLC 98,000$6,0000.00%
Newbridge Financial Services Group, Inc. 10,000$1,0000.00%
Western Wealth Management, LLC 352,950$11,0000.00%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 606,800$37,0000.00%
View complete list of AMPIO PHARMACEUTICALS INC shareholders